iCM 023
Alternative Names: ICM-023Latest Information Update: 17 May 2024
At a glance
- Originator iCoat Medical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Reperfusion injury
Most Recent Events
- 07 May 2024 Early research in Reperfusion injury in Sweden (unspecified route) prior to May 2024 (iCoat Medical pipeline; May 2024)
- 07 May 2024 Preclinical trials in Reperfusion injury in Sweden (unspecified route) prior to May 2024 (iCoat Medical pipeline; May 2024)